UNSPSC 51282101: Clavulanic acid

This classification denotes a beta-lactam antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23521W1S24. European Medicines Agency schedules Clavulanic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06642MIG. Clavulanic acid generally arises in the molecular formula C8H9NO5. The term CLAVULANIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21.) Most nations schedule clavulanic acid under HS 29349990 and SITC 51579.

As of Q4 2014, CLAVULANIC ACID remains the US FDA Preferred Term for this commodity. Clavulanic acid bears US NLM identifiers UMLS ID C0055860 and NCI Concept Code C61681. SMILES: O1C2N(C(C\1=C\CO)C(=O)O)C(=O)C2.

UNSPSC 51282101 Clavulanic acid is a Commodity code that nominally names a beta-lactamase inhibitor pharmaceutical ingredient, but recent state and local solicitations tagged with this code show little alignment with that specific product. Instead, the opportunities reflect procurement of broader pharmaceutical and medical supply categories—naloxone and drug deactivation systems, generic pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs—suggesting either misclassification in source systems or that the code serves as a catch-all for pharmaceutical and health-related medical goods. State and local buyers under this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Activity spans health emergency response, pharmacy benefit management, and community health initiatives.

Recent opportunities show geographic activity in Florida, Texas, Minnesota, and Oregon. Seminole County issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa issued an invitation to bid (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in participating jurisdictions, with awarded contracts effective July 1, 2026. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, functioning as preliminary market intelligence before formal competitive solicitation.